Logo

Beckman Coulter Posts Rise in Q2 Sales

Jul 26, 2004

NEW YORK, July 26 (GenomeWeb News) - Beckman Coulter reported today a roughly eight percent rise in second-quarter sales, driven in part by growth in the company's clinical diagnostics and biomedical research divisions.

 

Beckman Coulter's sales for the period were $597.3 million, up from $551.8 million in the second quarter 2003. Sales in the company's clinical diagnostics division climbed 10 percent on strong sales of the UniCel Dxl 800 immunoassay system, while sales in its biomedical division were up four percent.

 

Beckman Coulter posted net earnings of $58.3 million in the second quarter, an almost 12 percent increased over the $52.2 million recorded in same period last year.

 

Looking ahead, the company said that it expects sales in the third quarter to rise between eight and 11 percent, and total year sales to be up nine to 10 percent.

 

Breaking News
The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.